Hap Trading, LLC Standard Biotools Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.93 - $1.52 $1,023 - $1,672	-1,100 Reduced 2.53%	42,400 $0
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $770 - $1,442	700 Added 1.64%	43,500 $0
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.99 $480 - $1,197	-300 Reduced 0.7%	42,800 $4,000
Q1 2022 May 12, 2022	BUY	$2.8 - $3.96 $1,400 - $1,980	500 Added 1.17%	43,100 $11,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $154,638 - $261,138	42,600 New	42,600 $23,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $80,115 - $127,155	-14,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.34 - $11.43 $18,228 - $48,006	4,200 Added 40.0%	14,700 $19,000
Q2 2020 Aug 10, 2020	BUY	$1.85 - $5.29 $19,425 - $55,545	10,500 New	10,500 $1,000

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $91.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.